Welcome to LookChem.com Sign In|Join Free
  • or
MPEP, also known as 2-Methyl-6-(2-phenylethynyl)pyridine, is a potent, subtype-selective mGluR5 antagonist. It is a chemical compound that has been found to modulate the activity of the metabotropic glutamate receptor 5 (mGluR5), which plays a crucial role in various neurological processes.
Used in Pharmaceutical Industry:
MPEP is used as a research tool for studying the role of mGluR5 in neurological disorders and as a potential therapeutic agent for the treatment of such conditions.
Used in Alzheimer's Disease Research:
MPEP is used as a pharmacological agent to induce pathophysiological mGluR5 signaling in Alzheimer's disease model mice in a sex-selective manner. This helps researchers understand the role of mGluR5 in the progression of Alzheimer's disease and develop targeted therapies.
Used in Neurological Disorders Research:
MPEP is used as a potent, subtype-selective mGluR5 antagonist for investigating the role of mGluR5 in various neurological disorders, including Fragile X syndrome, schizophrenia, and drug addiction. Its ability to modulate mGluR5 activity makes it a valuable tool in the development of novel therapeutic strategies for these conditions.

96206-92-7

Post Buying Request

96206-92-7 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

96206-92-7 Usage

Biological Activity

Potent and highly selective non-competitive antagonist at the mGlu 5 receptor subtype (IC 50 = 36 nM) and a positive allosteric modulator at mGlu 4 receptors. Centrally active following systemic administration in vivo . Reverses mechanical hyperalgesia in the inflamed rat hind paw. Also available as part of the Group I mGlu Receptor Tocriset? .

references

[1] gasparini f, lingenh?hl k, stoehr n, et al. 2-methyl-6-(phenylethynyl)-pyridine (mpep), a potent, selective and systemically active mglu5 receptor antagonist. neuropharmacology, 1999, 38(10): 1493-1503.[2] tatarczyńska e, k?odzińska a, chojnacka-wójcik e, et al. potential anxiolytic-and antidepressant-like effects of mpep, a potent, selective and systemically active mglu5 receptor antagonist. british journal of pharmacology, 2001, 132(7): 1423-1430.

Check Digit Verification of cas no

The CAS Registry Mumber 96206-92-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,6,2,0 and 6 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 96206-92:
(7*9)+(6*6)+(5*2)+(4*0)+(3*6)+(2*9)+(1*2)=147
147 % 10 = 7
So 96206-92-7 is a valid CAS Registry Number.
InChI:InChI=1/C14H11N.ClH/c1-12-6-5-9-14(15-12)11-10-13-7-3-2-4-8-13;/h2-9H,1H3;1H

96206-92-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name MPEP hydrochloride,2-Methyl-6-(phenylethynyl)pyridinehydrochloride

1.2 Other means of identification

Product number -
Other names MPEP

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:96206-92-7 SDS

96206-92-7Relevant academic research and scientific papers

Mononuclear and dinuclear heteroleptic Cu(I) complexes based on pyridyl-triazole and DPEPhos with long-lived excited-state lifetimes

Bizzarri, Claudia,Arndt, Andreas P.,Kohaut, Stephan,Fink, Karin,Nieger, Martin

, p. 140 - 149 (2018/07/25)

A mononuclear and two dinuclear heteroleptic Cu(I) complexes have been successfully prepared, using the chelating bis [(2-diphenylphosphino)phenyl] ether (DPEPhos) and pyrid-2′-yl-1H-1,2,3-triazole as N?N chelating ligands. They show good luminescence in solution at room temperature with long-lived excited states. Furthermore, bimolecular quenching experiments of these new complexes with the catalyst Ni(cyclam)Cl2 encourage the use of such compounds as photosensitizers for the photoreduction of carbon dioxide.

Visible-light induced copper(i)-catalysed denitrogenative oxidative coupling of hydrazinylpyridines with terminal alkynes

Charpe, Vaibhav Pramod,Hande, Aniket A.,Sagadevan, Arunachalam,Hwang, Kuo Chu

supporting information, p. 4859 - 4864 (2018/11/21)

Visible light mediated copper catalysed denitrogenative oxidative coupling of 2-hydrazinopyridines with terminal alkynes to form 2-(alkyl/arylethynyl) pyridines in the presence of O2 at room temperature is reported with 42 examples. This is the first report on visible light stimulated N2 elimination by an in situ generated copper(ii) superoxo/peroxo complex. N2 and water are the only by-products. The green chemistry metrics evaluation signifies that the current method is ecofriendly and economically feasible. This method allows the green synthesis of mGluR5 receptor antagonists, 2-methyl-6-(phenylethynyl)pyridine (MPEP) and 2-((3-methoxyphenyl)ethynyl)-6-methylpyridine (M-MPEP).

Transformation of Carbonyl Compounds into Homologous Alkynes under Neutral Conditions: Fragmentation of Tetrazoles Derived from Cyanophosphates

Yoneyama, Hiroki,Numata, Masahiro,Uemura, Kenji,Usami, Yoshihide,Harusawa, Shinya

, p. 5538 - 5556 (2017/06/07)

Cyanophosphates (CPs) can be easily prepared from either ketones or aldehydes, and their reaction with NaN3-Et3N·HCl results in the formation of azidotetrazoles. Under microwave irradiation, successive fragmentation of the azidotetrazoles generates alkylidene carbenes that undergo [1,2]-rearrangement and are transformed into homologous alkynes. Treatment of ketone-derived CPs with TMSN3 and Bu2SnO as catalyst in toluene at reflux directly yields the corresponding internal alkynes, whereas the reaction of aldehyde-derived CPs with NaN3-Et3N·HCl in THF at reflux or TMSN3-Bu2SnO (cat.) in toluene at reflux provides homologous terminal alkynes in good yields. These reactions take place under neutral conditions and can be successfully extended to obtain alkynes that are not usually accessible from the corresponding carbonyl compounds by the Ohira-Bestmann or Shioiri procedures, which require basic conditions.

Palladium-catalyzed deacetonative coupling of aryl propargylic alcohols with aryl chlorides in water

Chang, Feng,Liu, Yanping

supporting information, p. 961 - 967 (2017/05/04)

A highly efficient and green process for palladium-catalyzed deacetonative coupling of aryl propargylic alcohols with aryl chlorides has been developed. The reaction occurs smoothly in neat water with 2 mol% PdCl2 as catalyst, and various synthetically useful functional groups, including ether, aldehyde, ketone, and heterocyclics, are well tolerated. Moreover, the reaction could proceed through a consecutive Sonogashira/deacetonative process using 2-methyl-3-butyn-2-ol and aryl chlorides as coupling partners, affording the symmetric alkynes in good yields.

Simultaneous rapid reaction workup and catalyst recovery

Lu, Zhichao,Hetman, Zofia,Hammond, Gerald B.,Xu, Bo

supporting information, p. 5769 - 5772 (2016/11/06)

By combining reaction work-up and catalyst recovery into a simple filtration procedure we have developed a substantially faster technique for organic synthesis. Our protocol eliminates the time-consuming conventional liquid-liquid extraction and is capable of parallelization and automation. Additionally, it requires only minimal amounts of solvent.

Phosphine-free palladium-catalyzed decarboxylative coupling of alkynylcarboxylic acids with aryl and heteroaryl halides

Reddy, Police Vishnuvardhan,Srinivas, Pottabathula,Annapurna, Manne,Bhargava, Suresh,Wagler, Jorg,Mirzadeh, Nedaossadat,Kantam, Mannepalli Lakshmi

supporting information, p. 705 - 710 (2013/04/23)

We herein report the design and development of a carboxyamido/carbene ligand and its Pd-complex for the decarboxylative coupling of alkynylcarboxylic acids with aryl and heteroaryl halides to afford arylalkynes. Copyright

Double arylation of diynes and alkynylation of functionalized heteroaryl halides by a practical heck reaction in an ionic liquid

Saleh, Samer,Picquet, Michel,Meunier, Philippe,Hierso, Jean-Cyrille

experimental part, p. 2844 - 2848 (2012/01/11)

The efficient palladium-catalyzed alkynylation of electron-rich bromoheteroarenes, incorporating deactivating electron-donating methyl and methoxy groups, and the (hetero)arylation of diynes, take place in the imidazolium ionic liquid [BMIM][BF4/sub

A novel palladium-catalyzed cross-coupling of thiomethylated alkynes with functionalized organozinc reagents

Melzig, Laurin,Stemper, Jeremy,Knochel, Paul

experimental part, p. 2085 - 2091 (2010/08/19)

A range of methylthio-substituted acetylenes undergo smooth palladium-catalyzed cross-coupling reactions with functionalized aryl-, heteroaryl-, and alkylzinc reagents using the Pd(OAc)2/DPE-Phos catalytic system at 25 or 50 C without the need for copper salts. Georg Thieme Verlag Stuttgart.

Synthesis and biological evaluation of fenobam analogs as mGlu5 receptor antagonists

Jaeschke, Georg,Porter, Richard,Buettelmann, Bernd,Ceccarelli, Simona M.,Guba, Wolfgang,Kuhn, Bernd,Kolczewski, Sabine,Huwyler, Joerg,Mutel, Vincent,Peters, Jens-Uwe,Ballard, Theresa,Prinssen, Eric,Vieira, Eric,Wichmann, Juergen,Spooren, Will

, p. 1307 - 1311 (2007/10/03)

Optimization of affinity and microsomal stability led to identification of the potent, metabolically stable fenobam analog 4l. Robust in vivo efficacy of 4l was demonstrated in four different models of anxiety. Additionally, a ligand based pharmacophore a

Synthesis and receptor assay of aromatic-ethynyl-aromatic derivatives with potent mGluR5 antagonist activity

Alagille, David,Baldwin, Ronald M.,Roth, Bryan L.,Wroblewski, Jarda T.,Grajkowska, Ewa,Tamagnan, Gilles D.

, p. 197 - 209 (2007/10/03)

Noncompetitive antagonists of the human metabotropic glutamate receptor subtype 5 (mGluR5) have been implicated as potential therapeutics for the treatment of a variety of nervous system disorders, including pain, anxiety, and drug addiction. To discover novel noncompetitive antagonists to the mGluR5, we initiated an SAR study around the known lead compounds MPEP and M-MPEP. Our results pointed out the critical role of the para position of the two aromatic rings, which leads to inactive products and permitted the discovery of potent mGluR5 antagonists (e.g., 16, 25, 28, 34 IC50 = 13.5, 11.9, 21, 15 nM, respectively). Noncompetitive antagonists of the human metabotropic glutamate receptor subtype 5 (mGluR5) have been implicated as potential therapeutics for the treatment of a variety of nervous system disorders, including pain, anxiety, and drug addiction. To discover novel noncompetitive antagonists to the mGluR5, we initiated an SAR study around the known lead compounds MPEP and M-MPEP. Our results pointed out the critical role of the para position of the two aromatic rings, which leads to inactive products and permitted the discovery of potent mGluR5 antagonists (e.g., 16, 25, 28, 34 IC50 = 13.5, 11.9, 21, 15 nM, respectively).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 96206-92-7